Startup Profile: Lactiga (020)

Episode 20 September 05, 2021 00:48:50
Startup Profile: Lactiga (020)
Innovation4Alpha
Startup Profile: Lactiga (020)

Sep 05 2021 | 00:48:50

/

Show Notes

Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. They are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world’s most dangerous pathogens including Covid. Lactiga has earned multiple awards, media attention (Globe & Mail, CTV, Toronto Star) and is participating in the On Deck Health (ODH2) cohort.

AngelMD Profile: https://www.angelmd.co/en/startups/lactiga

Other Episodes

Episode 30

August 24, 2022 00:28:03
Episode Cover

Pacific Echelon Security Services: Innovation & Hyper Growth in Physical Security (230)

Alex Stone is the Founder/CEO of Pacific Echelon Security Services, one of the fastest growing security companies in the United States.  The company is...

Listen

Episode 10

April 15, 2022 00:47:00
Episode Cover

Triple Threat - Clinician, Researcher & Teacher: Ian Sarembock, MD (210)

Ian Sarembock, MD - is a retired Coronary & Structural Interventionalist and was previously the Harold C. Schott Endowed Chair in Structural Heart at...

Listen

Episode 16

August 04, 2021 00:35:31
Episode Cover

Featured Family Office: Nottingham Spirk / Katherine Hill Ritchie (016)

Katherine Hill Ritchie has extensive background running single family offices including a strong emphasis on sourcing alternative investments. Her most recent role involves both...

Listen